The Japanese regulatory authority has approved mega-blockbuster drug Humira (adalimumab) for the treatment of hidradenitis suppurativa (HS).
Source link
Related
https://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.png
0
0
Steve
https://higenix.com/wp-content/uploads/2018/09/higenix-hs-treatment.png
Steve2019-02-21 15:00:242019-02-21 15:00:24Humira becomes first treatment of hidradenitis suppurativa in Japan
Leave a Reply
Want to join the discussion?Feel free to contribute!